-
1
-
-
84863621527
-
Cancer epigenetics: From mechanism to therapy
-
10.1016/j.cell.2012.06.013 22770212
-
Cancer epigenetics: from mechanism to therapy. Dawson MA, Kouzarides T, Cell 2012 150 1 12 27 10.1016/j.cell.2012.06.013 22770212
-
(2012)
Cell
, vol.150
, Issue.1
, pp. 12-27
-
-
Dawson, M.A.1
Kouzarides, T.2
-
2
-
-
33847084602
-
Genome Regulation by Polycomb and Trithorax Proteins
-
DOI 10.1016/j.cell.2007.02.009, PII S0092867407001900
-
Genome regulation by polycomb and trithorax proteins. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G, Cell 2007 128 4 735 745 10.1016/j.cell.2007.02.009 17320510 (Pubitemid 46273581)
-
(2007)
Cell
, vol.128
, Issue.4
, pp. 735-745
-
-
Schuettengruber, B.1
Chourrout, D.2
Vervoort, M.3
Leblanc, B.4
Cavalli, G.5
-
3
-
-
79952384705
-
Cancer epigenetics reaches mainstream oncology
-
21386836
-
Cancer epigenetics reaches mainstream oncology. Rodriguez-Paredes M, Esteller M, Nat Med 2011 17 3 330 339 21386836
-
(2011)
Nat Med
, vol.17
, Issue.3
, pp. 330-339
-
-
Rodriguez-Paredes, M.1
Esteller, M.2
-
4
-
-
31144459985
-
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
-
DOI 10.1038/nature04296, PII NATURE04296
-
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al. Nature 2006 439 7074 353 357 10.1038/nature04296 16273092 (Pubitemid 43128862)
-
(2006)
Nature
, vol.439
, Issue.7074
, pp. 353-357
-
-
Bild, A.H.1
Yao, G.2
Chang, J.T.3
Wang, Q.4
Potti, A.5
Chasse, D.6
Joshi, M.-B.7
Harpole, D.8
Lancaster, J.M.9
Berchuck, A.10
Olson Jr., J.A.11
Marks, J.R.12
Dressman, H.K.13
West, M.14
Nevins, J.R.15
-
5
-
-
0347090327
-
Adjustment of systematic microarray data biases
-
DOI 10.1093/bioinformatics/btg385
-
Adjustment of systematic microarray data biases. Benito M, Parker J, Du Q, Wu J, Xiang D, Perou CM, Marron JS, Bioinformatics 2004 20 1 105 114 10.1093/bioinformatics/btg385 14693816 (Pubitemid 38094234)
-
(2004)
Bioinformatics
, vol.20
, Issue.1
, pp. 105-114
-
-
Benito, M.1
Parker, J.2
Du, Q.3
Wu, J.4
Xiang, D.5
Perou, C.M.6
Marron, J.S.7
-
6
-
-
0035949684
-
Predicting the clinical status of human breast cancer by using gene expression profiles
-
DOI 10.1073/pnas.201162998
-
Predicting the clinical status of human breast cancer by using gene expression profiles. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, Nevins JR, Proc Natl Acad Sci USA 2001 98 20 11462 11467 10.1073/pnas.201162998 11562467 (Pubitemid 32928751)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.20
, pp. 11462-11467
-
-
West, M.1
Blanchette, C.2
Dressman, H.3
Huang, E.4
Ishida, S.5
Spang, R.6
Zuzan, H.7
Olson Jr., J.A.8
Marks, J.R.9
Nevins, J.R.10
-
7
-
-
84874271270
-
NCBI GEO: Archive for functional genomics data sets - Update
-
10.1093/nar/gks1193 23193258
-
NCBI GEO: archive for functional genomics data sets - update. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. Nucleic acids research 2013 41 991 995 10.1093/nar/gks1193 23193258
-
(2013)
Nucleic Acids Research
, vol.41
, pp. 4991-4995
-
-
Barrett, T.1
Wilhite, S.E.2
Ledoux, P.3
Evangelista, C.4
Kim, I.F.5
Tomashevsky, M.6
Marshall, K.A.7
Phillippy, K.H.8
Sherman, P.M.9
Holko, M.10
-
8
-
-
84876097557
-
ArrayExpress update - Trends in database growth and links to data analysis tools
-
10.1093/nar/gks1174 23193272
-
ArrayExpress update - trends in database growth and links to data analysis tools. Rustici G, Kolesnikov N, Brandizi M, Burdett T, Dylag M, Emam I, Farne A, Hastings E, Ison J, Keays M, et al. Nucleic acids research 2013 41 987 990 10.1093/nar/gks1174 23193272
-
(2013)
Nucleic Acids Research
, vol.41
, pp. 4987-4990
-
-
Rustici, G.1
Kolesnikov, N.2
Brandizi, M.3
Burdett, T.4
Dylag, M.5
Emam, I.6
Farne, A.7
Hastings, E.8
Ison, J.9
Keays, M.10
-
9
-
-
27344435774
-
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
-
DOI 10.1073/pnas.0506580102
-
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Proc Natl Acad Sci USA 2005 102 43 15545 15550 10.1073/pnas.0506580102 16199517 (Pubitemid 41528093)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.43
, pp. 15545-15550
-
-
Subramanian, A.1
Tamayo, P.2
Mootha, V.K.3
Mukherjee, S.4
Ebert, B.L.5
Gillette, M.A.6
Paulovich, A.7
Pomeroy, S.L.8
Golub, T.R.9
Lander, E.S.10
Mesirov, J.P.11
-
10
-
-
0037458031
-
Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics
-
DOI 10.1073/pnas.242716699
-
Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M, Delmonte T, Villeneuve A, Sladek R, Xu F, et al. Proc Natl Acad Sci USA 2003 100 2 605 610 10.1073/pnas.242716699 12529507 (Pubitemid 36126099)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.2
, pp. 605-610
-
-
Mootha, V.K.1
Lepage, P.2
Miller, K.3
Bunkenborg, J.4
Reich, M.5
Hjerrild, M.6
Delmonte, T.7
Villeneuve, A.8
Sladek, R.9
Xu, F.10
Mitchell, G.A.11
Morin, C.12
Mann, M.13
Hudson, T.J.14
Robinson, B.15
Rioux, J.D.16
Lander, E.S.17
-
11
-
-
33751384465
-
GATHER: A systems approach to interpreting genomic signatures
-
DOI 10.1093/bioinformatics/btl483
-
GATHER: a systems approach to interpreting genomic signatures. Chang JT, Nevins JR, Bioinformatics 2006 22 23 2926 2933 10.1093/bioinformatics/btl483 17000751 (Pubitemid 44811565)
-
(2006)
Bioinformatics
, vol.22
, Issue.23
, pp. 2926-2933
-
-
Chang, J.T.1
Nevins, J.R.2
-
12
-
-
84859169877
-
The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity
-
10.1038/nature11003 22460905
-
The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, et al. Nature 2012 483 7391 603 607 10.1038/nature11003 22460905
-
(2012)
Nature
, vol.483
, Issue.7391
, pp. 603-607
-
-
Barretina, J.1
Caponigro, G.2
Stransky, N.3
Venkatesan, K.4
Margolin, A.A.5
Kim, S.6
Wilson, C.J.7
Lehar, J.8
Kryukov, G.V.9
Sonkin, D.10
-
13
-
-
84855392434
-
EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR
-
10.1158/0008-5472.CAN-11-0961 22068036
-
EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei JS, Marquez VE, Bates SE, Jin Q, Khan J, et al. Cancer Res 2012 72 1 315 324 10.1158/0008-5472.CAN-11-0961 22068036
-
(2012)
Cancer Res
, vol.72
, Issue.1
, pp. 315-324
-
-
Wang, C.1
Liu, Z.2
Woo, C.W.3
Li, Z.4
Wang, L.5
Wei, J.S.6
Marquez, V.E.7
Bates, S.E.8
Jin, Q.9
Khan, J.10
-
14
-
-
79953680754
-
Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells
-
10.1093/nar/gkq864 20952403
-
Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. Angrisano T, Sacchetti S, Natale F, Cerrato A, Pero R, Keller S, Peluso S, Perillo B, Avvedimento VE, Fusco A, et al. Nucleic Acids Res 2011 39 6 1993 2006 10.1093/nar/gkq864 20952403
-
(2011)
Nucleic Acids Res
, vol.39
, Issue.6
, pp. 1993-2006
-
-
Angrisano, T.1
Sacchetti, S.2
Natale, F.3
Cerrato, A.4
Pero, R.5
Keller, S.6
Peluso, S.7
Perillo, B.8
Avvedimento, V.E.9
Fusco, A.10
-
15
-
-
46149115160
-
HDAC4 inhibits cell-cycle progression and protects neurons from cell death
-
DOI 10.1002/dneu.20637
-
HDAC4 inhibits cell-cycle progression and protects neurons from cell death. Majdzadeh N, Wang L, Morrison BE, Bassel-Duby R, Olson EN, D'Mello SR, Dev Neurobiol 2008 68 8 1076 1092 10.1002/dneu.20637 18498087 (Pubitemid 351904928)
-
(2008)
Developmental Neurobiology
, vol.68
, Issue.8
, pp. 1076-1092
-
-
Majdzadeh, N.1
Wang, L.2
Morrison, B.E.3
Bassel-Duby, R.4
Olson, E.N.5
D'Mello, S.R.6
-
16
-
-
84866324536
-
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1
-
10.1158/2159-8290.CD-12-0112 22961666
-
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, et al. Cancer Discov 2012 2 9 798 811 10.1158/2159-8290.CD-12-0112 22961666
-
(2012)
Cancer Discov
, vol.2
, Issue.9
, pp. 798-811
-
-
Byers, L.A.1
Wang, J.2
Nilsson, M.B.3
Fujimoto, J.4
Saintigny, P.5
Yordy, J.6
Giri, U.7
Peyton, M.8
Fan, Y.H.9
Diao, L.10
-
17
-
-
84867569866
-
Different expression of EZH2, BMI1 and Ki67 in low and high grade neuroendocrine tumors of the lung
-
23011159
-
Different expression of EZH2, BMI1 and Ki67 in low and high grade neuroendocrine tumors of the lung. Bondgaard AL, Poulsen TT, Poulsen HS, Skov BG, Cancer Biomark 2012 11 2-3 123 128 23011159
-
(2012)
Cancer Biomark
, vol.11
, Issue.2-3
, pp. 123-128
-
-
Bondgaard, A.L.1
Poulsen, T.T.2
Poulsen, H.S.3
Skov, B.G.4
-
18
-
-
79959267832
-
Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
-
10.1111/j.1349-7006.2011.01958.x 21539681
-
Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Takawa M, Masuda K, Kunizaki M, Daigo Y, Takagi K, Iwai Y, Cho HS, Toyokawa G, Yamane Y, Maejima K, et al. Cancer Sci 2011 102 7 1298 1305 10.1111/j.1349-7006.2011.01958.x 21539681
-
(2011)
Cancer Sci
, vol.102
, Issue.7
, pp. 1298-1305
-
-
Takawa, M.1
Masuda, K.2
Kunizaki, M.3
Daigo, Y.4
Takagi, K.5
Iwai, Y.6
Cho, H.S.7
Toyokawa, G.8
Yamane, Y.9
Maejima, K.10
-
19
-
-
80055077899
-
HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia
-
10.1074/jbc.M111.257055 21917920
-
HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia. Geng H, Harvey CT, Pittsenbarger J, Liu Q, Beer TM, Xue C, Qian DZ, J Biol Chem 2011 286 44 38095 38102 10.1074/jbc.M111.257055 21917920
-
(2011)
J Biol Chem
, vol.286
, Issue.44
, pp. 38095-38102
-
-
Geng, H.1
Harvey, C.T.2
Pittsenbarger, J.3
Liu, Q.4
Beer, T.M.5
Xue, C.6
Qian, D.Z.7
-
20
-
-
33749006252
-
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α
-
DOI 10.1158/0008-5472.CAN-05-4598
-
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha. Qian DZ, Kachhap SK, Collis SJ, Verheul HM, Carducci MA, Atadja P, Pili R, Cancer Res 2006 66 17 8814 8821 10.1158/0008-5472.CAN-05-4598 16951198 (Pubitemid 44449199)
-
(2006)
Cancer Research
, vol.66
, Issue.17
, pp. 8814-8821
-
-
Qian, D.Z.1
Kachhap, S.K.2
Collis, S.J.3
Verheul, H.M.W.4
Carducci, M.A.5
Atadja, P.6
Pili, R.7
-
21
-
-
33744954457
-
Differential expression of selected histone modifier genes in human solid cancers
-
DOI 10.1186/1471-2164-7-90
-
Differential expression of selected histone modifier genes in human solid cancers. Ozdag H, Teschendorff AE, Ahmed AA, Hyland SJ, Blenkiron C, Bobrow L, Veerakumarasivam A, Burtt G, Subkhankulova T, Arends MJ, et al. BMC Genomics 2006 7 90 10.1186/1471-2164-7-90 16638127 (Pubitemid 43852761)
-
(2006)
BMC Genomics
, vol.7
, pp. 90
-
-
Ozdag, H.1
Teschendorff, A.E.2
Ahmed, A.A.3
Hyland, S.J.4
Blenkiron, C.5
Bobrow, L.6
Veerakumarasivam, A.7
Burtt, G.8
Subkhankulova, T.9
Arends, M.J.10
Collins, V.P.11
Bowtell, D.12
Kouzarides, T.13
Brenton, J.D.14
Caldas, C.15
-
22
-
-
48249100925
-
A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers
-
10.1371/journal.pgen.1000129 18636107
-
A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers. Yu K, Ganesan K, Tan LK, Laban M, Wu J, Zhao XD, Li H, Leung CH, Zhu Y, Wei CL, et al. PLoS Genetics 2008 4 7 1000129 10.1371/journal.pgen.1000129 18636107
-
(2008)
PLoS Genetics
, vol.4
, Issue.7
, pp. 51000129
-
-
Yu, K.1
Ganesan, K.2
Tan, L.K.3
Laban, M.4
Wu, J.5
Zhao, X.D.6
Li, H.7
Leung, C.H.8
Zhu, Y.9
Wei, C.L.10
-
23
-
-
77955094541
-
Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition
-
10.1016/j.biocel.2010.05.006 20580679
-
Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition. Lei W, Zhang K, Pan X, Hu Y, Wang D, Yuan X, Shu G, Song J, Int J Biochem Cell Biol 2010 42 9 1489 1497 10.1016/j.biocel.2010.05.006 20580679
-
(2010)
Int J Biochem Cell Biol
, vol.42
, Issue.9
, pp. 1489-1497
-
-
Lei, W.1
Zhang, K.2
Pan, X.3
Hu, Y.4
Wang, D.5
Yuan, X.6
Shu, G.7
Song, J.8
-
24
-
-
37049001617
-
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma
-
DOI 10.1159/000111106
-
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Rikimaru T, Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, Shimada M, Maehara Y, Oncology 2007 72 1-2 69 74 18004079 (Pubitemid 350249132)
-
(2007)
Oncology
, vol.72
, Issue.1-2
, pp. 69-74
-
-
Rikimaru, T.1
Taketomi, A.2
Yamashita, Y.-I.3
Shirabe, K.4
Hamatsu, T.5
Shimada, M.6
Maehara, Y.7
-
25
-
-
84867790360
-
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor response
-
10.1021/jm3011838 23061376
-
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor response. Wong JC, Tang G, Wu X, Liang C, Zhang Z, Guo L, Peng Z, Zhang W, Lin X, Wang Z, et al. J Med Chem 2012 55 20 8903 8925 10.1021/jm3011838 23061376
-
(2012)
J Med Chem
, vol.55
, Issue.20
, pp. 8903-8925
-
-
Wong, J.C.1
Tang, G.2
Wu, X.3
Liang, C.4
Zhang, Z.5
Guo, L.6
Peng, Z.7
Zhang, W.8
Lin, X.9
Wang, Z.10
-
26
-
-
78651506355
-
High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients
-
20844838
-
High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Cai MY, Hou JH, Rao HL, Luo RZ, Li M, Pei XQ, Lin MC, Guan XY, Kung HF, Zeng YX, et al. Mol Med 2011 17 1-2 12 20 20844838
-
(2011)
Mol Med
, vol.17
, Issue.1-2
, pp. 12-20
-
-
Cai, M.Y.1
Hou, J.H.2
Rao, H.L.3
Luo, R.Z.4
Li, M.5
Pei, X.Q.6
Lin, M.C.7
Guan, X.Y.8
Kung, H.F.9
Zeng, Y.X.10
-
27
-
-
79957912993
-
EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis
-
10.1158/0008-5472.CAN-10-3342 21512140
-
EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis. Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, et al. Cancer Res 2011 71 11 4028 4039 10.1158/0008-5472.CAN-10-3342 21512140
-
(2011)
Cancer Res
, vol.71
, Issue.11
, pp. 4028-4039
-
-
Cheng, A.S.1
Lau, S.S.2
Chen, Y.3
Kondo, Y.4
Li, M.S.5
Feng, H.6
Ching, A.K.7
Cheung, K.F.8
Wong, H.K.9
Tong, J.H.10
-
28
-
-
84859157028
-
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
-
10.1002/ijc.26264 21717453
-
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells. Chiba T, Suzuki E, Negishi M, Saraya A, Miyagi S, Konuma T, Tanaka S, Tada M, Kanai F, Imazeki F, et al. Int J Cancer 2012 130 11 2557 2567 10.1002/ijc.26264 21717453
-
(2012)
Int J Cancer
, vol.130
, Issue.11
, pp. 2557-2567
-
-
Chiba, T.1
Suzuki, E.2
Negishi, M.3
Saraya, A.4
Miyagi, S.5
Konuma, T.6
Tanaka, S.7
Tada, M.8
Kanai, F.9
Imazeki, F.10
-
29
-
-
0035127794
-
Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis
-
DOI 10.1053/jhep.2001.22507
-
Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S, Hepatology 2001 33 3 561 568 10.1053/jhep.2001.22507 11230735 (Pubitemid 32185217)
-
(2001)
Hepatology
, vol.33
, Issue.3
, pp. 561-568
-
-
Saito, Y.1
Kanai, Y.2
Sakamoto, M.3
Saito, H.4
Ishii, H.5
Hirohashi, S.6
-
30
-
-
74249098871
-
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
-
10.1186/1471-2407-9-461 20028503
-
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma. He LR, Liu MZ, Li BK, Rao HL, Liao YJ, Guan XY, Zeng YX, Xie D, BMC Cancer 2009 9 461 10.1186/1471-2407-9-461 20028503
-
(2009)
BMC Cancer
, vol.9
, pp. 461
-
-
He, L.R.1
Liu, M.Z.2
Li, B.K.3
Rao, H.L.4
Liao, Y.J.5
Guan, X.Y.6
Zeng, Y.X.7
Xie, D.8
-
31
-
-
84871052080
-
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent
-
10.1126/science.1227604 23239736
-
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, et al. Science 2012 338 6113 1465 1469 10.1126/science. 1227604 23239736
-
(2012)
Science
, vol.338
, Issue.6113
, pp. 1465-1469
-
-
Xu, K.1
Wu, Z.J.2
Groner, A.C.3
He, H.H.4
Cai, C.5
Lis, R.T.6
Wu, X.7
Stack, E.C.8
Loda, M.9
Liu, T.10
-
32
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
DOI 10.1073/pnas.191367098
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Proc Natl Acad Sci USA 2001 98 19 10869 10874 10.1073/pnas.191367098 11553815 (Pubitemid 32878711)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.19
, pp. 10869-10874
-
-
Sorlie, T.1
Perou, C.M.2
Tibshirani, R.3
Aas, T.4
Geisler, S.5
Johnsen, H.6
Hastie, T.7
Eisen, M.B.8
Van De Rijn, M.9
Jeffrey, S.S.10
Thorsen, T.11
Quist, H.12
Matese, J.C.13
Brown, P.O.14
Botstein, D.15
Lonning, P.E.16
Borresen-Dale, A.-L.17
-
33
-
-
62449131093
-
Supervised risk predictor of breast cancer based on intrinsic subtypes
-
10.1200/JCO.2008.18.1370 19204204
-
Supervised risk predictor of breast cancer based on intrinsic subtypes. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al. J Clin Oncol 2009 27 8 1160 1167 10.1200/JCO.2008.18.1370 19204204
-
(2009)
J Clin Oncol
, vol.27
, Issue.8
, pp. 1160-1167
-
-
Parker, J.S.1
Mullins, M.2
Cheang, M.C.3
Leung, S.4
Voduc, D.5
Vickery, T.6
Davies, S.7
Fauron, C.8
He, X.9
Hu, Z.10
-
34
-
-
73649123907
-
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
-
10.1016/j.ccr.2009.12.020 20129251
-
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. Cancer Cell 2010 17 1 98 110 10.1016/j.ccr.2009.12. 020 20129251
-
(2010)
Cancer Cell
, vol.17
, Issue.1
, pp. 98-110
-
-
Verhaak, R.G.1
Hoadley, K.A.2
Purdom, E.3
Wang, V.4
Qi, Y.5
Wilkerson, M.D.6
Miller, C.R.7
Ding, L.8
Golub, T.9
Mesirov, J.P.10
-
35
-
-
79960570375
-
A pharmacogenomic method for individualized prediction of drug sensitivity
-
21772261
-
A pharmacogenomic method for individualized prediction of drug sensitivity. Cohen AL, Soldi R, Zhang H, Gustafson AM, Wilcox R, Welm BE, Chang JT, Johnson E, Spira A, Jeffrey SS, et al. Mol Syst Biol 2011 7 513 21772261
-
(2011)
Mol Syst Biol
, vol.7
, pp. 513
-
-
Cohen, A.L.1
Soldi, R.2
Zhang, H.3
Gustafson, A.M.4
Wilcox, R.5
Welm, B.E.6
Chang, J.T.7
Johnson, E.8
Spira, A.9
Jeffrey, S.S.10
-
36
-
-
77958540564
-
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
-
10.1186/bcr2590 20565864
-
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jonsson G, Olsson H, Borg A, Ringner M, Breast Cancer Res 2010 12 3 36 10.1186/bcr2590 20565864
-
(2010)
Breast Cancer Res
, vol.12
, Issue.3
, pp. 1836
-
-
Holm, K.1
Hegardt, C.2
Staaf, J.3
Vallon-Christersson, J.4
Jonsson, G.5
Olsson, H.6
Borg, A.7
Ringner, M.8
-
37
-
-
84866516020
-
Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer
-
10.1016/j.humpath.2011.12.004
-
Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer. Hussein YR, Sood AK, Bandyopadhyay S, Albashiti B, Semaan A, Nahleh Z, Roh J, Han HD, Lopez-Berestein G, Ali-Fehmi R, Human Pathol 2012 43 10 1638 1644 10.1016/j.humpath.2011.12.004
-
(2012)
Human Pathol
, vol.43
, Issue.10
, pp. 1638-1644
-
-
Hussein, Y.R.1
Sood, A.K.2
Bandyopadhyay, S.3
Albashiti, B.4
Semaan, A.5
Nahleh, Z.6
Roh, J.7
Han, H.D.8
Lopez-Berestein, G.9
Ali-Fehmi, R.10
-
38
-
-
84856518779
-
Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes
-
22037257
-
Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes. Park SY, Kwon HJ, Choi Y, Lee HE, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH, Mod Pathol 2012 25 2 185 196 22037257
-
(2012)
Mod Pathol
, vol.25
, Issue.2
, pp. 185-196
-
-
Park, S.Y.1
Kwon, H.J.2
Choi, Y.3
Lee, H.E.4
Kim, S.W.5
Kim, J.H.6
Kim, I.A.7
Jung, N.8
Cho, N.Y.9
Kang, G.H.10
-
39
-
-
78951487862
-
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
-
10.1016/j.molonc.2010.11.002
-
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, et al. Molecular Oncol 2011 5 1 77 92 10.1016/j.molonc.2010.11.002
-
(2011)
Molecular Oncol
, vol.5
, Issue.1
, pp. 77-92
-
-
Kamalakaran, S.1
Varadan, V.2
Giercksky Russnes, H.E.3
Levy, D.4
Kendall, J.5
Janevski, A.6
Riggs, M.7
Banerjee, N.8
Synnestvedt, M.9
Schlichting, E.10
-
40
-
-
34447544566
-
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells
-
DOI 10.1128/MCB.00162-07
-
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Shi B, Liang J, Yang X, Wang Y, Zhao Y, Wu H, Sun L, Zhang Y, Chen Y, Li R, et al. Mol Cellular Biol 2007 27 14 5105 5119 10.1128/MCB.00162-07 (Pubitemid 47068285)
-
(2007)
Molecular and Cellular Biology
, vol.27
, Issue.14
, pp. 5105-5119
-
-
Shi, B.1
Liang, J.2
Yang, X.3
Wang, Y.4
Zhao, Y.5
Wu, H.6
Sun, L.7
Zhang, Y.8
Chen, Y.9
Li, R.10
Zhang, Y.11
Hong, M.12
Shang, Y.13
-
41
-
-
80052222327
-
Context-specific regulation of NF-kappaB target gene expression by EZH2 in breast cancers
-
10.1016/j.molcel.2011.08.011 21884980
-
Context-specific regulation of NF-kappaB target gene expression by EZH2 in breast cancers. Lee ST, Li Z, Wu Z, Aau M, Guan P, Karuturi RK, Liou YC, Yu Q, Mol Cell 2011 43 5 798 810 10.1016/j.molcel.2011.08.011 21884980
-
(2011)
Mol Cell
, vol.43
, Issue.5
, pp. 798-810
-
-
Lee, S.T.1
Li, Z.2
Wu, Z.3
Aau, M.4
Guan, P.5
Karuturi, R.K.6
Liou, Y.C.7
Yu, Q.8
-
42
-
-
79955765058
-
DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression
-
DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, et al. Neurooncol 2011 13 3 280 289
-
(2011)
Neurooncol
, vol.13
, Issue.3
, pp. 280-289
-
-
Zheng, S.1
Houseman, E.A.2
Morrison, Z.3
Wrensch, M.R.4
Patoka, J.S.5
Ramos, C.6
Haas-Kogan, D.A.7
McBride, S.8
Marsit, C.J.9
Christensen, B.C.10
-
43
-
-
84864828790
-
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
-
10.1186/1471-2407-12-306 22824040
-
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. Medrek C, Ponten F, Jirstrom K, Leandersson K, BMC Cancer 2012 12 306 10.1186/1471-2407-12-306 22824040
-
(2012)
BMC Cancer
, vol.12
, pp. 306
-
-
Medrek, C.1
Ponten, F.2
Jirstrom, K.3
Leandersson, K.4
-
44
-
-
84864863792
-
CCR5 antagonist blocks metastasis of basal breast cancer cells
-
10.1158/0008-5472.CAN-11-3917 22637726
-
CCR5 antagonist blocks metastasis of basal breast cancer cells. Velasco-Velazquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A, Lisanti MP, Pestell RG, Cancer Res 2012 72 15 3839 3850 10.1158/0008-5472.CAN-11-3917 22637726
-
(2012)
Cancer Res
, vol.72
, Issue.15
, pp. 3839-3850
-
-
Velasco-Velazquez, M.1
Jiao, X.2
De La Fuente, M.3
Pestell, T.G.4
Ertel, A.5
Lisanti, M.P.6
Pestell, R.G.7
-
45
-
-
84870439234
-
The cancer stem cell subtype determines immune infiltration of glioblastoma
-
10.1089/scd.2011.0660 22676416
-
The cancer stem cell subtype determines immune infiltration of glioblastoma. Beier CP, Kumar P, Meyer K, Leukel P, Bruttel V, Aschenbrenner I, Riemenschneider MJ, Fragoulis A, Rummele P, Lamszus K, et al. Stem Cells Dev 2012 21 15 2753 2761 10.1089/scd.2011.0660 22676416
-
(2012)
Stem Cells Dev
, vol.21
, Issue.15
, pp. 2753-2761
-
-
Beier, C.P.1
Kumar, P.2
Meyer, K.3
Leukel, P.4
Bruttel, V.5
Aschenbrenner, I.6
Riemenschneider, M.J.7
Fragoulis, A.8
Rummele, P.9
Lamszus, K.10
-
46
-
-
84870989699
-
Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients
-
10.1007/s00262-012-1283-8 22618884
-
Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. Herrera AC, Panis C, Victorino VJ, Campos FC, Colado-Simao AN, Cecchini AL, Cecchini R, Cancer Immunol Immunother 2012 61 11 2193 2201 10.1007/s00262-012-1283-8 22618884
-
(2012)
Cancer Immunol Immunother
, vol.61
, Issue.11
, pp. 2193-2201
-
-
Herrera, A.C.1
Panis, C.2
Victorino, V.J.3
Campos, F.C.4
Colado-Simao, A.N.5
Cecchini, A.L.6
Cecchini, R.7
|